GPT Healthcare IPO

GPT Healthcare Limited

₹14,160 /80 sharesMinimum Investment

GPT Healthcare IPO Listing Details

Listed OnIssue PriceListing PriceListing Gains
BSE & NSE₹186.00₹216.00₹30.00 (16.13%)

GPT Healthcare IPO Details

Bidding DatesMin. InvestmentLot SizePrice Range
22 Feb ‘24 - 26 Feb ‘24₹14,16080₹177 - ₹186
Issue SizeIPO Doc
525.14Cr
RHP PDF

Subscription Status As on Invalid Date

  • Qualified Institutional Buyers
    17.30x
  • Non-Institutional Investor
    11.02x
  • Retail Individual Investor
    2.44x
  • Total
    8.52x

About GPT Healthcare

GPT Healthcare Limited is a healthcare player in Eastern India with four mid-sized full-service hospitals in West Bengal and Tripura, offering 561 beds in total. The company offers secondary and tertiary care across 35 specialties under the brand name ILS Hospitals. The company’s offerings include intensive care, neurology, nephrology (including kidney transplant), orthopaedics and joint replacement, internal medicine and diabetology, neurosurgery, integrated diagnostic services, gynaecology and obstetrics, laparoscopic and general surgery, gastroenterology, interventional cardiology, paediatrics, neonatology and pharmacy services.;
Parent Organisation
GPT Healthcare Limited
Founded
1989
Managing Director
Dr. Om Tantia

Strengths & Risks

  • As per a CRISIL report for Fiscal year 2023, GPT Healthcare is one of the key regional corporate healthcare companies in Eastern India in terms of number of beds and hospitals. The company has been operational in the region for the past 20 years.
  • The company has a diversified service portfolio as a multispecialty healthcare platform. This has allowed it to have diversified revenue streams. In addition to providing core medical, surgical, and emergency services, it provides complex and advanced healthcare in specialities, such as nephrology (including renal transplants), diabetology etc.
  • The company has expanded over the years by increasing the bed capacity of its hospitals from eight beds in July 2000 to 561 beds as of September 30, 2023. Its team of medical professionals have also increased over the years. From a staff of 945 in 2021, the company has a team of 1312 medical professionals as of Sep 30, 2023.
  • It reported total operational revenues of Rs. 361.04 cr, Rs. 337.42 cr, and Rs. 242.75 cr, for Fiscal Years 2023, 2022, and 2021 respectively.
  • The company generates about 70% of its operational revenue from hospitals located in West Bengal, serving a substantial portion of its patient base. With all hospitals situated in the eastern region of India, any adverse effects on the revenue or alterations in the economic or political landscape of West Bengal could have a significant impact on the company's business, financial condition, operational results, and cash flows.
  • A member of the Promoter Group, Ishwari Prasad Tantia, has been listed as a Wilful Defaulter by some financial institutions. Future adverse actions or penalties against any Promoter Group member or associated entities by banks, RBI, SEBI, or regulatory authorities may adversely affect the company's reputation and business operations.
  • The company, along with its Promoters and Directors, is involved in certain legal proceedings, and any adverse developments may impact its operations. Potential litigation expenses and liabilities could adversely affect the company's reputation, business, financial condition, and cash flows.
  • The company has certain commitments and contingent liabilities that may adversely affect its financial condition. As of September 2023, its contingent liabilities amounted to Rs. 1.8 cr.
  • The company relies on third-party suppliers and manufacturers for supplies and equipment. Failure of such third parties to meet their obligations could adversely affect the business, results of operations and cash flows.

Financials

*All values are in Rs. Cr
No Graph Data To Display

Application details

Apply asPrice bandApply upto
Regular177 - 186₹2 Lakh
High Networth Individual177 - 186₹2 - 5 Lakh
For GPT Healthcare IPO, eligible investors can apply as Regular.
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.8.7
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ

ABOUT GROWW